Key Trend Reshaping the Tumor Ablation Therapy Devices Market in 2025: Innovations In Tumor Ablation Therapy Devices By Leading Companies

What Are the Projections for the Size and Growth Rate of the Tumor Ablation Therapy Devices Market?
In recent times, the market size of tumor ablation therapy devices has experienced significant growth. Expected to rise from a value of $0.72 billion in 2024 to $0.83 billion in 2025, the market will exhibit a compound annual growth rate (CAGR) of 15.0%. The historical growth can be traced back to factors such as the incidence rate of cancer, advancements in technology, an aging population, and the introduction of minimally invasive procedures.

The market size for tumor ablation therapy devices is set to experience a brisk expansion in the upcoming years. Forecasts predict a growth to $1.44 billion by 2029 with a compound annual growth rate (CAGR) of 14.8%. Several factors such as personalized medicine, combination therapies, usage of AI and image-guided ablation, telemedicine along with remote consultations, and training and education are contributing to this surge during the forecast period. It is anticipated that enhancements in ablation technologies, imaging guidance, contribution of robotics and navigation systems, integration with immuno-oncology, percutaneous and image-guided ablation will be the major trends in the projected period.

What Are the Main Catalysts for Growth in the Tumor Ablation Therapy Devices Market?
The escalating incidence of cancer worldwide is a leading contributor to the expansion of the tumor ablation therapy devices market. Regarded as the second dominant cause of global mortality, approximately 1 in 6 deaths are attributed to cancer. Tumor ablation, a medical procedure involving minimal invasion, is extensively employed for treating cancerous tumors located in the lungs, liver, kidneys, and bones. The American Cancer Society Inc., a non-profit health organization operating in the US, predicts that 1,958,310 new instances of cancer will be detected in the country in 2023, exhibiting an advance from over 1,918,030 novel cases that were reported in 2022. The process offers an impactful remedy for patients unresponsive to chemotherapy or radiotherapy, boosting the positive trajectory of the tumor ablation therapy devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp

Which Businesses Are at the Forefront of Tumor Ablation Therapy Devices Market Development?
Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

What Are the Latest Innovations in the Tumor Ablation Therapy Devices Market?
Leading firms in the tumor ablation therapy devices sector are striving for technological enhancements that enable quicker processes, heightened safety, diminished radiation exposure, accelerated learning curves, and superior results. J&J medicals have introduced a cutting-edge microwave ablation system, NEUWAVE. This offers a groundbreaking minimally invasive option that involves inserting electrodes into cancer cells and raising the surrounding temperature, in order to effectively kill cancer cells. For example, Compal Electronics, originating in Taiwan, introduced AblatePal in April 2023. This is a newly conceptualized radiofrequency ablation (RFA) system purposed for the percutaneous, intraoperative coagulation and ablation of soft tissue. It includes the partial or full treatment of non-resectable liver lesions. The system works by utilizing the thermal energy released through electrical resistance when the current traverses the tissue, leading to the ultimate removal of the specific target tissue. This system is applicable in therapeutic medical devices and is particularly tailored to address a broad spectrum of medical conditions, especially cancer.

How Is the Tumor Ablation Therapy Devices Market Segmented?
The tumor ablation therapy devices market covered in this report is segmented -

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users

Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Where Is the Tumor Ablation Therapy Devices Market Growth Most Prominent?
North America was the largest region in the tumor ablation therapy devices market in 2023. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Tumor Ablation Therapy Devices Global Market Report?

- Market Size Analysis: Analyze the Tumor Ablation Therapy Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Tumor Ablation Therapy Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Tumor Ablation Therapy Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Tumor Ablation Therapy Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3351

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.